In this article, the constrained adaptive control strategy based on virotherapy is investigated for organism using the medicine dosage regulation mechanism (MDRM). First, the tumor-virus-immune interaction dynamics is established to model the relations among the tumor cells (TCs), virus particles, and the immune response. The adaptive dynamic programming (ADP) method is extended to approximately obtain the optimal strategy for the interaction system to reduce the populations of TCs. Due to the consideration of asymmetric control constraints, the nonquadratic functions are proposed to formulate the value function such that the corresponding Hamilton-Jacobi-Bellman equation (HJBE) is derived which can be deemed as the cornerstone of ADP algorithms. Then, the ADP method of a single-critic network architecture which integrates MDRM is proposed to obtain the approximate solutions of HJBE and eventually derive the optimal strategy. The design of MDRM makes it possible for the dosage of the agentia containing oncolytic virus particles to be regulated timely and necessarily. Furthermore, the uniform ultimate boundedness of the system states and critic weight estimation errors is validated by Lyapunov stability analysis. Finally, simulation results are given to show the effectiveness of the derived therapeutic strategy.

Download full-text PDF

Source
http://dx.doi.org/10.1109/TCYB.2023.3241344DOI Listing

Publication Analysis

Top Keywords

medicine dosage
8
dosage regulation
8
regulation mechanism
8
virus particles
8
adp method
8
optimal strategy
8
strategy
5
adaptive virotherapy
4
virotherapy strategy
4
strategy organism
4

Similar Publications

Pharmacogenomics stands as a pivotal driver toward personalized medicine, aiming to optimize drug efficacy while minimizing adverse effects by uncovering the impact of genetic variations on inter-individual outcome variability. Despite its promise, the intricate landscape of drug metabolism introduces complexity, where the correlation between drug response and genes can be shaped by numerous nongenetic factors, often exhibiting heterogeneity across diverse subpopulations. This challenge is particularly pronounced in datasets such as the International Warfarin Pharmacogenetic Consortium (IWPC), which encompasses diverse patient information from multiple nations.

View Article and Find Full Text PDF

Hepatitis B (Hep B) remains a critical public health issue globally, particularly in Tibet, where vaccination rates and influencing factors among college students are yet understudied. This study applies a cross-sectional design to investigate the Hep B vaccination rate among 1,126 college students in Tibet and utilizes the expanded theory of planned behavior (ETPB) to identify vaccination behavior intention (BI) and vaccination behavior (VB). Stratified cluster sampling across three universities was used to assess behavioral attitudes (BA), subjective norms (SN), perceived behavioral control (PBC), past vaccination history (PVH) and vaccination knowledge (VK), and used structural equation modeling (SEM) for model validation and multi-group comparison.

View Article and Find Full Text PDF

Background: Meeting protein intake recommendations is relevant for maintaining muscle mass. This study aimed to describe protein intake and its association with meal patterns and dietary patterns.

Methods: An in-house designed, web-based 4-day record was used in the national dietary survey (in 2010/2011).

View Article and Find Full Text PDF

Effectiveness and Safety of Dose-Specific DOACs in Patients With Atrial Fibrillation: A Systematic Review and Network Meta-Analysis.

Cardiovasc Ther

January 2025

College of Pharmacy and Institute of Pharmaceutical Science and Technology, Hanyang University, Ansan-si, Gyeonggi-do, Republic of Korea.

Dose adjustments of direct-acting oral anticoagulants (DOACs) for atrial fibrillation are based on pivotal clinical trials assessing their effectiveness and safety in controlled settings. However, the appropriateness of these dosing strategies in real-world practice is uncertain. The purpose of this study is to compare the effectiveness and safety of dose-specific DOACs with those of warfarin.

View Article and Find Full Text PDF

Human Umbilical Cord-Mesenchymal Stem Cells Combined With Low Dosage Nintedanib Rather Than Using Alone Mitigates Pulmonary Fibrosis in Mice.

Stem Cells Int

January 2025

Department of Respiratory Medicine Children's Hospital of Chongqing Medical University, National Clinical Research Center for Child Health and Disorders, Ministry of Education Key Laboratory of Child Development and Disorders, Chongqing 400014, China.

Pulmonary fibrosis (PF) is a lethal pathological change of fibrotic interstitial lung diseases (ILDs) with abundant fibroblasts proliferation after severely or continually alveolar epithelial cells (AECs) injury. Barely therapies are helpful for PF. Here we use bleomycin intratracheally injection to model PF with or without human umbilical cord-mesenchymal stem cells (hUC-MSCs) and/or nintedanib intervention.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!